The Brain Tumour Foundation of Canada’s Feature Grant supports outstanding researchers conducting quality brain tumour research, with the 2026 cycle emphasizing glioblastoma (GBM). The program funds basic, clinical, translational, and population-based studies, welcoming innovative proposals with novel concepts and collaborative, multidisciplinary teams.
Eligibility Criteria:
Applicants must:
- Hold an appointment at a Canadian university, research institute, or hospital
- Propose a project to be performed in Canada
- Not have received a Brain Tumour Foundation of Canada grant in the previous year; prior recipients may reapply two years after their initial award (with submitted reports)
- Submit only one proposal per applicant per cycle
Funding Details:
- Total funding: Up to CAD $50,000
- Duration: Up to 2 years
- Indirect costs: Not specified; capital equipment not funded; travel limited to ≤5% of budget
Deadline:
- LOI due: N/A (no LOI stage — direct full application)
- Full application due: May 15, 2026, 4:30 PM ET (no exceptions) ,
- Award notification: August 2026
Where to go for further information:
- Current Funding Opportunities – Brain Tumour Foundation of Canada
- 2026 Feature Grant Guidelines (PDF)
- Contact: Susan Ruypers, Manager of Mission Support and Resources — sruypers@braintumour.ca